Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer

Published:2010-12 Issue:12 Volume:5 Page:1963-1969
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Socinski Mark A.,Raju Robert N.,Stinchcombe Thomas,Kocs Darren M.,Couch Linda S.,Barrera David,Rousey Steven R.,Choksi Janak K.,Jotte Robert,Patt Debra A.,Periman Phillip O.,Schlossberg Howard R.,Weissman Charles H.,Wang Yunfei,Asmar Lina,Pritchard Sharon,Bromund Jane,Peng Guangbin,Treat Joseph,Obasaju Coleman K.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference43 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Screening, diagnosis, and staging of lung cancer;Shepherd;Curr Opin Oncol,1993

3. Chemotherapy for advanced non-small-cell lung cancer;Walling;Respir Med,1994

4. Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?;Grilli;J Clin Oncol,1993

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signaling dynamics in coexisting monoclonal cell subpopulations unveil mechanisms of resistance to anti-cancer compounds;Cell Communication and Signaling;2024-07-26

2. An Update on Protein Kinases as Therapeutic Targets—Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases;International Journal of Molecular Sciences;2023-12-18

3. Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis;Open Medicine;2023-01-01

4. Is area under the curve the best parameter for carboplatin induced emetic risk stratification?;NAGOYA J MED SCI;2021

5. Protein Kinase C as a Therapeutic Target in Non-Small Cell Lung Cancer;International Journal of Molecular Sciences;2021-05-24